This suggests that, while FXR and TGR5 are both important for reducing atherosclerosis and inflammation, FXR’s role in lowering lipids is not critical for INT-767’s ability to reduce atherosclerotic lesion size. This evidence concerns the gene NR1H4 and atherosclerosis.